Depinar, a drug that potentially inhibits the binding and entry of COVID-19 into host cells based on computer-aided studies

• Egile Nagusiak: Meysam Yazdani (Egilea), Jafar Khezri (Egilea), Nastaran Hadizadeh (Egilea), Javad Zamani Amir Zakaria (Egilea), Mousa Naderi (Egilea), Sahar Mahmoodian (Egilea), Ali Asghar Karkhanei (Egilea), Farideh Razi (Egilea), Mohammad Hossein Sanati (Egilea), Ehsan Hashemi (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background and purpose: The new coronavirus (Covid-19) has resulted in great global concerns. Due to the mortality of this virus, scientists from all over the world have been trying to employ different strategies to tackle down this concern. This virus enters cells via phagocytosis through binding t...